Full-Length Spine CT and MRI in Daily Practice

2022 ◽  
pp. 143-149
Author(s):  
Stephane Bourret ◽  
Tae-Keun Ahn ◽  
Wendy Thompson ◽  
Cecile Roscop ◽  
Thibault Cloché ◽  
...  
2020 ◽  
Vol 11 (05) ◽  
pp. 270-281
Author(s):  
Tae-Keun Ahn ◽  
Stephane Bourret ◽  
Wendy Thompson ◽  
Cecile Roscop ◽  
Thibault Cloché ◽  
...  
Keyword(s):  
Spine Ct ◽  

Author(s):  
Jasminka Igrec ◽  
Michael H. Fuchsjäger

Background In the diagnosis of bone and soft-tissue sarcomas, the continuous advancement of various imaging modalities has improved the detection of small lesions, surgical planning, assessment of chemotherapeutic effects, and, importantly, guidance for surgery or biopsy. Method This review was composed based on a PubMed literature search for the terms “bone sarcoma,” “bone cancer” and “soft tissue sarcoma,” “imaging,” “magnetic resonance imaging”, “computed tomography”, “ultrasound”, “radiography”, and “radiomics” covering the publication period 2005–2020. Results and Conclusion As discussed in this review, radiography, ultrasound, CT, and MRI all play key roles in the imaging evaluation of bone and soft-tissue sarcomas. In daily practice, advanced MRI techniques complement standard MRI but remain underused, as they are considered time-consuming, technically challenging, and not reliable enough to replace biopsy and histology. PET/MRI and radiomics have shown promise regarding the imaging of sarcomas in the future. Key Points:  Citation Format


Radiology ◽  
1993 ◽  
Vol 186 (1) ◽  
pp. 226-226
Author(s):  
Jannice O. Aaron
Keyword(s):  
Spine Ct ◽  

1994 ◽  
Vol 4 (4) ◽  
pp. 332-336 ◽  
Author(s):  
P. Reginster ◽  
J. Collignon ◽  
R. F. Dondelinger

1991 ◽  
Vol 12 (1) ◽  
pp. 79-80
Author(s):  
J.T. Wilmink
Keyword(s):  
Spine Ct ◽  

1997 ◽  
Vol 26 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Christine Chung ◽  
Joseph S. Yu ◽  
Donald Resnick ◽  
Luke M. Vaughan ◽  
Parvis Haghighi

1994 ◽  
Vol 24 (1) ◽  
pp. 75-75
Author(s):  
T. Jaspan
Keyword(s):  
Spine Ct ◽  

Author(s):  
C. Jennermann ◽  
S. A. Kliewer ◽  
D. C. Morris

Peroxisome proliferator-activated receptor gamma (PPARg) is a member of the nuclear hormone receptor superfamily and has been shown in vitro to regulate genes involved in lipid metabolism and adipocyte differentiation. By Northern analysis, we and other researchers have shown that expression of this receptor predominates in adipose tissue in adult mice, and appears first in whole-embryo mRNA at 13.5 days postconception. In situ hybridization was used to find out in which developing tissues PPARg is specifically expressed.Digoxigenin-labeled riboprobes were generated using the Genius™ 4 RNA Labeling Kit from Boehringer Mannheim. Full length PPAR gamma, obtained by PCR from mouse liver cDNA, was inserted into pBluescript SK and used as template for the transcription reaction. Probes of average size 200 base pairs were made by partial alkaline hydrolysis of the full length transcripts. The in situ hybridization assays were performed as described previously with some modifications. Frozen sections (10 μm thick) of day 18 mouse embryos were cut, fixed with 4% paraformaldehyde and acetylated with 0.25% acetic anhydride in 1.0M triethanolamine buffer. The sections were incubated for 2 hours at room temperature in pre-hybridization buffer, and were then hybridized with a probe concentration of 200μg per ml at 70° C, overnight in a humidified chamber. Following stringent washes in SSC buffers, the immunological detection steps were performed at room temperature. The alkaline phosphatase labeled, anti-digoxigenin antibody and detection buffers were purchased from Boehringer Mannheim. The sections were treated with a blocking buffer for one hour and incubated with antibody solution at a 1:5000 dilution for 2 hours, both at room temperature. Colored precipitate was formed by exposure to the alkaline phosphatase substrate nitrobluetetrazoliumchloride/ bromo-chloroindlylphosphate.


Sign in / Sign up

Export Citation Format

Share Document